FDA is seeking consumer representatives to serve on the Oncologic Drugs Advisory Committee.
Astera Cancer Care, a partner of the One Oncology Network, has partnered with Knowtex to develop advanced voice and generative AI workflows tailored specifically for oncology.
In 1996, Lei Zheng, a graduate of Peking Union Medical College, enrolled in the doctorate program at what was then known as the Cancer Therapy & Research Center in San Antonio.
NCI Director Kimryn Rathmell has released her professional judgment budget proposal, requesting nearly $11.5 billion—the same amount as last year’s proposal prepared by her predecessor, Monica Bertagnolli.
A study recently published in JAMA sheds light on cancer risks associated with carrying germline CDH1 mutations, challenging previous, potentially inflated, lifetime cancer risk estimates.
Laurie Glimcher to step down as Dana-Farber president and CEO, Benjamin Levine Ebert named successor
Laurie H. GlimcherBenjamin Levine EbertLaurie H. Glimcher will step down as Dana-Farber Cancer Institute president and CEO on Oct. 1.
The Advanced Research Projects Agency for Health announced the first eight teams selected by its Precision Surgical Interventions, or PSI, program to receive awards.
Bill King, a researcher with the University of Illinois Urbana-Champaign, received a $18.7 million award from the Advanced Research Projects Agency for Health to develop a novel platform to manufacture tumor models and dramatically expand their availability for both medical research and personalized medicine.
McKesson Corp. has signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures LLC (Core Ventures).
A partnership between Florida Cancer Specialists & Research Institute and Paradigm Health Inc. will provide patients in Florida with more access to new treatment options through participation in clinical trials.
